Underuse of the health care system by persons with diabetes mellitus and diabetic macular edema in the United States

JAMA Ophthalmology

Volumn 132, Issue 2, 2014, Pages 168-173

  Bressler, Neil M ^a   Varma, Rohit ^b   Doan, Quan V ^c   Gleeson, Michelle ^c   Danese, Mark ^c   Bower, Julie K ^d   Selvin, Elizabeth ^d   Dolan, Chantal ^e   Fine, Jennifer ^e   Colman, Shoshana ^e   Turpcu, Adam ^e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c Outcomes Insights Inc   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS-SECTIONAL STUDIES; DELIVERY OF HEALTH CARE; DIABETIC RETINOPATHY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES RESEARCH; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; UNITED STATES; VISUAL ACUITY;

EID: 84894228476     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2013.6426     Document Type: Article

References (24)

1. Centers for Disease Control and Prevention. National diabetes fact sheet, 2011. http://www.cdc.gov/diabetes/pubs/pdf/ndfs-2011.pdf. Accessed April 30, 2013.
2. Roy MS, Klein R, O'Colmain BJ, Klein BE, Moss SE, Kempen JH. The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States. Arch Ophthalmol. 2004;122(4):546-551.
3. Congdon N, O'Colmain B, Klaver CC, et al; Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122(4):477-485.
4. Prevent Blindness America. Vision problems in the US: prevalence of adult vision impairment and age-related eye disease in America: 2008 update to the fourth edition. 2008. http://www .preventblindness.net/site/docserver/vpus-2008- update.pdf. Accessed April 30, 2013.
5. Klein R, Lee KE, Gangnon RE, Klein BE. The 25-year incidence of visual impairment in type 1 diabetes mellitus: theWisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology. 2010;117(1):63-70.
6. American Academy of Ophthalmology Retina/Vitreous Panel. Preferred Practice Pattern® guidelines: diabetic retinopathy. San Francisco, CA: American Academy of Ophthalmology; 2008. http://www.aao.org/ppp. Accessed April 30, 2013.
7. Ferris FL III. How effective are treatments for diabetic retinopathy? JAMA. 1993;269(10):1290-1291.
8. American Diabetes Association. Standards of medical care in diabetes: 2013. Diabetes Care. 2013;36(suppl 1):S11-S66.
9. Elman MJ, Qin H, Aiello LP, et al; Diabetic Retinopathy Clinical Research Network. Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. Ophthalmology. 2012;119(11):2312-2318.
10. Rajendram R, Fraser-Bell S, Kaines A, et al. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 1. Arch Ophthalmol. 2012;130(8):972-979
11. Nguyen QD, Brown DM, Marcus DM, et al; RISE and RIDE Research Group. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology. 2012;119(4):789-801.
12. Mitchell P, Bandello F, Schmidt-Erfurth U, et al; RESTORE Study Group. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology. 2011;118(4):615-625.
13. Do DV, Nguyen QD, Boyer D, et al; da VINCI Study Group. One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema. Ophthalmology. 2012;119(8):1658-1665.
14. OhjiM, Ishibashi T; REVEAL Study Group. Efficacy and safety of ranibizumab 0.5mg as monotherapy or adjunctive to laser versus laser monotherapy in Asian patients with visual impairment due to diabetic macular edema: 12-month results of the REVEAL study. Presented at: the Association for Research in Vision and Ophthalmology Annual Meeting; May 9, 2012; Fort Lauderdale, FL.
15. Centers for Disease Control and Prevention. About the National Health and Nutrition Examination Survey. http://www.cdc.gov/nchs /nhanes/about-nhanes.htm. Updated April 2, 2013. Accessed April 30, 2013.
16. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey (NHANES): ophthalmology procedures manual. http://www.cdc.gov/nchs/data/nhanes/nhanes-05-06/OP.pdf. Updated September 2005. Accessed April 30, 2013.
17. Centers for Disease Control and Prevention. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94: series 1: programs and collection procedures. Vital Health Stat 2 July 1994(32):1-407
18. National Center for Health Statistics and the Centers for Disease Control and Prevention. Analytic and reporting guidelines: the National Health and Nutrition Examination Survey (NHANES). http://www.cdc.gov/nchs/data/nhanes /nhanes-03-04/nhanes-analytic-guidelines-dec-2005.pdf. Accessed March 25, 2013.
19. Centers for Disease Control and Prevention. NHANES 1999-2000 addendum to the NHANES III analytic guidelines. http://www.cdc.gov/nchs/data/nhanes/ guidelines1.pdf. Updated August 30, 2002. Accessed April 30, 2013.
20. Moss SE, Klein R, Klein BE. Ten-year incidence of visual loss in a diabetic population. Ophthalmology. 1994;101(6):1061-1070.
21. Klein R, Klein BE. Vision disorders in diabetes. In: Harris MI, Cowie CC, SteraMP, Reiber GE, Bennett PH, eds. Diabetes in America. 2nd ed. Bethesda, MD: National Diabetes Data Group of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; 1995:293-338. http://diabetes.niddk.nih.gov/dm /pubs/america/pdf/chapter14.pdf. Accessed April 30, 2013.
22. Varma R, Bressler NM, Doan Q, et al. African Americans at highest risk of diabetic macular edema compared with non-Hispanic whites and Hispanics: the prevalence of and risks for diabetic macular edema from the National Health and Nutrition Examination Survey. Presented at: the American Academy of Ophthalmology 2012 Annual Meeting; November 11, 2012; Chicago, IL.
23. National Committee for Quality Assurance. Continuous improvement and the expansion of quality measurement: the state of health care quality 2011.Washington, DC: National Committee for Quality Assurance; 2011. http://www.ncqa.org /Portals/0/SOHC-web1.pdf. Accessed April 30, 2013.
24. Diabetic Retinopathy Clinical Research Network (DRCRnet). Effect of diabetes education during retinal ophthalmology visits on diabetes control. DRCR.net public website. http://drcrnet.jaeb.org/Studies.aspx?RecID=197. Accessed April 30, 2013.